Company Overview and News
Stop missing out on important events!
Chicago, IL – March 21, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include UnitedHealth (UNH - Free Report) , Morgan Stanley (MS - Free Report) , Anheuser-Busch (BUD - Free Report) , Cigna (CI - Free Report) and Intuitive Surgical (ISRG - Free Report) . (55-0)
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Morgan Stanley (MS) and Anheuser-Busch (BUD). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. (172-0)
About nine months ago, Google co-founder Sergey Brin and Johnson & Johnson CEO Alex Gorsky showed up at the Silicon Valley office of a start-up called Verb Surgical. They challenged each other to use robotic arms to put sutures into a squishy, synthetic tissue.
This article provides an introductory fundamental overview and technical analysis of three stocks in the burgeoning medical robotics industry. (8-1)
In the era of big data, unless one's portfolio is in tune with the evolving digital trend, making prudent investment choices can prove to be a daunting task. Millennials have started to recognize the increasing need of the emerging automation trend and subsequently robotics, IoT, 3D printing are becoming part of our daily life with the latest buzzword being Artificial Intelligence (AI). (225-0)
American workers, for the first time, are discovering how much employees earn at the biggest U.S. companies and how that pay compares with the chief executive’s. (1-0)
Suppose there was an exchange traded fund that focused on the single most important technology trend in the world today. You might think that I was smoking California’s largest export (it’s not grapes). But such a fund DOES exist. The Global X Robotics & Artificial Intelligence ETF (BOTZ) drops a golden opportunity into investors’ laps as a way to capture part of the growing movement behind automation. (718-3)
One out of three of the hedged portfolios I presented in Week 15 outperformed its expected return. (227-1)
The consensus is so overwhelmingly bearish on bonds - after they have been crushed - that I have gotten interested in them. (195-0)
Good morning. Thank you for joining us for the Stereotaxis’ Fourth Quarter 2017 Earnings Conference Call. Certain statements during this conference call and question-and-answer period to follow may relate to future events, expectations, and as such, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company in the future to be materially different from the statements that the company’s executives may make today. (3-0)
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, March 5. (9-0)
On February 20, 2018, Johnson & Johnson (JNJ) announced the acquisition of Orthotaxy through its French subsidiary Apsis to develop its robot-assisted orthopedics surgery platform. The price has not been disclosed. That day, JNJ stock fell 1.7%. The Vanguard High Dividend Yield ETF (VYM) fell 0.96% that day. JNJ stock makes up ~3.4% of VYM’s total portfolio. (8-0)
Long-time listeners will have heard me joke before that this podcast should really be called This Is Who You’re Up Against. I’ve been waiting for the right episode to deploy the joke as a title, and this week we have it. The joke’s meant to convey how incredibly impressive these people are who we get to hear from every week. My guest this week is Josh Wolfe, a founding and managing partner at Lux Capital in New York City.
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
When there’s not much to say, sometimes it’s prudent to not say anything at all. However, due to the volatility over the last month, it seems necessary to break the silence, evaluate what is currently occurring, and put some perspective on what is expected moving forward. Inevitably, when markets correct, something is changing and we ought to try and identify what that is. (877-1)